Using the money to redesign RGN assets for use in the clinical trials. Question is "when" will they be ready for action.
With the redesign, will this involve new patent applications for the redesigns? Will ENDV want to file those patent applications prior to clinical trials or after trial is proven effective?
Still waiting for the patent application from May 2017 to have updated status....Zzzzzzz